The Worldwide Incidence and Prevalence of Primary Brain Tumors: a Systematic Review and Meta-analysis

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2014 Oct 15

PMID 25313193

Citations 121

Authors

Paula de Robles

Kirsten M Fiest

Alexandra D Frolkis

Tamara Pringsheim

Callie Atta

Christine St Germaine-Smith

Lundy Day

Darren Lam

Nathalie Jette

Affiliations

Soon will be listed here.

Abstract

Background: Primary brain tumors are a heterogeneous group of benign and malignant tumors arising from the brain parenchyma and its surrounding structures. The epidemiology of these tumors is poorly understood. The aim of our study is to systematically review the latest literature on the incidence and prevalence of primary brain tumors.

Methods: The systematic review and meta-analysis were conducted according to a predetermined protocol and established guidelines. Only studies reporting on data from 1985 onward were included. Articles were included if they met the following criteria: (i) original research, (ii) population based, (iii) reported an incidence or prevalence estimate of primary brain tumors.

Results: From the 53 eligible studies overall, 38 were included in the meta-analysis. A random-effects model found the overall incidence rate of all brain tumors to be 10.82 (95% CI: 8.63-13.56) per 100 000 person-years. The incidence proportion estimates were heterogeneous, even among the same tumor subtypes, and ranged from 0.051 per 100 000 (germ cell tumors) to 25.48 per 100 000 (all brain tumors). There were insufficient data to conduct a meta-analysis of the prevalence of primary brain tumors.

Conclusions: There is a need for more accurate and comparable incidence and prevalence estimates of primary brain tumors across the world. A standardized approach to the study of the epidemiology of these tumors is needed to better understand the burden of brain tumors and the possible geographical variations in their incidence.

Citing Articles

Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review.

Mansour H, Shah S, Aguilar T, Abdul-Muqsith M, Gonzales-Portillo G, Mehta A Cancers (Basel). 2024; 16(23).

PMID: 39682171 PMC: 11639985. DOI: 10.3390/cancers16233984.

RNASE4 promotes malignant progression and chemoresistance in hypoxic glioblastoma via activation of AXL/AKT and NF-κB/cIAPs signaling pathways.

Lee H, Chuang H, Lin K, Yeh C, Wang Y, Chi H Am J Cancer Res. 2024; 14(9):4320-4336.

PMID: 39417186 PMC: 11477813. DOI: 10.62347/UDBJ5986.

An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery.

Susa F, Arpicco S, Pirri C, Limongi T Pharmaceutics. 2024; 16(7).

PMID: 39065547 PMC: 11279990. DOI: 10.3390/pharmaceutics16070849.

Biological Activity of Natural and Synthetic Peptides as Anticancer Agents.

Bauso L, La Fauci V, Munao S, Bonfiglio D, Armeli A, Maimone N Int J Mol Sci. 2024; 25(13).

PMID: 39000371 PMC: 11242495. DOI: 10.3390/ijms25137264.

Ten Priorities for Research Addressing the Intersections of Brain Injury, Mental Health and Addictions: A Stakeholder-Driven Priority-Setting Study.

Kennedy C, Woodin E, Schmidt J, Biagioni J, Garcia-Barrera M Health Expect. 2024; 27(4):e14136.

PMID: 38990165 PMC: 11238575. DOI: 10.1111/hex.14136.

References

Nilsson B, Bengtsson B, Jonsson B . Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab. 2000; 85(4):1420-5. DOI: 10.1210/jcem.85.4.6498. View

Brown M, Schrot R, Bauer K, Dodge J . Incidence of first primary central nervous system tumors in California, 2001-2005: children, adolescents and teens. J Neurooncol. 2009; 94(2):263-73. DOI: 10.1007/s11060-009-9860-1. View

Chan M, Teo W, Seow W, Tan A . Epidemiology, management and treatment outcome of medulloblastoma in singapore. Ann Acad Med Singap. 2007; 36(5):314-8. View

Loney P, Chambers L, Bennett K, Roberts J, Stratford P . Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1999; 19(4):170-6. View

Lee C, Jung K, Yoo H, Park S, Lee S . Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 2010; 48(2):145-52. PMC: 2941858. DOI: 10.3340/jkns.2010.48.2.145. View

Dobec-Meic B, Pikija S, Cvetko D, Trkulja V, Pazanin L, Kudelic N . Intracranial tumors in adult population of the Varazdin County (Croatia) 1996-2004: a population-based retrospective incidence study. J Neurooncol. 2006; 78(3):303-10. DOI: 10.1007/s11060-005-9100-2. View

Pobereskin L, Chadduck J . Incidence of brain tumours in two English counties: a population based study. J Neurol Neurosurg Psychiatry. 2000; 69(4):464-71. PMC: 1737141. DOI: 10.1136/jnnp.69.4.464. View

Klaeboe L, Lonn S, Scheie D, Auvinen A, Christensen H, Feychting M . Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005; 117(6):996-1001. DOI: 10.1002/ijc.21255. View

McNally R, Kelsey A, Cairns D, Taylor G, Eden O, Birch J . Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954-1998) are likely to be real. Cancer. 2001; 92(7):1967-76. DOI: 10.1002/1097-0142(20011001)92:7<1967::aid-cncr1716>3.0.co;2-#. View

10.

Counsell C, Collie D, Grant R . Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. J Neurol Neurosurg Psychiatry. 1996; 61(2):143-50. PMC: 1073987. DOI: 10.1136/jnnp.61.2.143. View

11.

Farinotti M, Ferrarini M, Solari A, Filippini G . Incidence and survival of childhood CNS tumours in the Region of Lombardy, Italy. Brain. 1998; 121 ( Pt 8):1429-36. DOI: 10.1093/brain/121.8.1429. View

12.

Al-Sheyyab M, Bateiha A, Kayed S, Hajjawi B . The incidence of childhood cancer in Jordan: a population-based study. Ann Saudi Med. 2006; 23(5):260-3. DOI: 10.5144/0256-4947.2003.260. View

13.

Alston R, Newton R, Kelsey A, Newbould M, Birch J, Lawson B . Childhood medulloblastoma in northwest England 1954 to 1997: incidence and survival. Dev Med Child Neurol. 2003; 45(5):308-14. DOI: 10.1017/s0012162203000586. View

14.

Freedman L, Barchana M, Al-Kayed S, Qasem M, Young J, Edwards B . A comparison of population-based cancer incidence rates in Israel and Jordan. Eur J Cancer Prev. 2003; 12(5):359-65. DOI: 10.1097/00008469-200310000-00003. View

15.

Lacy J, Saadati H, Yu J . Complications of brain tumors and their treatment. Hematol Oncol Clin North Am. 2012; 26(4):779-96. DOI: 10.1016/j.hoc.2012.04.007. View

16.

Giordana M, Schiffer P, Lanotte M, Girardi P, Chio A . Epidemiology of adult medulloblastoma. Int J Cancer. 1999; 80(5):689-92. DOI: 10.1002/(sici)1097-0215(19990301)80:5<689::aid-ijc10>3.0.co;2-g. View

17.

Liigant A, Asser T, Kulla A, Kaasik A . Epidemiology of primary central nervous system tumors in Estonia. Neuroepidemiology. 2000; 19(6):300-11. DOI: 10.1159/000026269. View

18.

Davis F, Malinski N, Haenszel W, Chang J, Flannery J, Gershman S . Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study. Neuroepidemiology. 1996; 15(2):103-12. DOI: 10.1159/000109895. View

19.

Werner M, Phuphanich S, Lyman G . The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 1995; 76(9):1634-42. DOI: 10.1002/1097-0142(19951101)76:9<1634::aid-cncr2820760921>3.0.co;2-0. View

20.

Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Desandes E, Clavel J . Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004. Eur J Cancer Prev. 2010; 19(3):173-81. DOI: 10.1097/cej.0b013e32833876c0. View